Flamazine cream discontinuation
The supplier, Smith & Nephew, has advised that it will stop supplying Flamazine cream (Pharmacode: 2343851) sulfadiazine silver 1% to the New Zealand market.
Affected product
The supplier expects to cease supplying stock for prescription use in approximately December 2026 or January 2027. Supply of Flamazine for retail use ended in September 2026.
- Chemical: Sulfadiazine silver 1%
- Brand: Flamazine
- Pharmacode: 2343851
- Subsidy: $10.80
- Measure / Qty: per 50 g
Key dates
September 2026 | Supply for retail use has been ceased.
December 2026/January 2027 | Supplier estimates they will stop supplying stock for prescription use to pharmacy wholesalers.
What's Pharmac doing?
Pharmac is working on arrangements for future supply of silver sulfadiazine cream to maintain continuity of supply once Flamazine stock is exhausted. We will provide an update once we have further information.
We're sorry
We know that changes to medicines like this can be disruptive. Unfortunately, the supplier has made the decision to stop the supply of this medicine.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)